A phase II study of live-attenuated Listeria monocytogenes immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).
Warner King Huh
No relevant relationships to disclose
William E. Brady
No relevant relationships to disclose
Kathleen N. Moore
No relevant relationships to disclose
Heather A. Lankes
No relevant relationships to disclose
Bradley J. Monk
No relevant relationships to disclose
Carol Aghajanian
No relevant relationships to disclose
Don S. Dizon
No relevant relationships to disclose
Paula M. Fracasso
No relevant relationships to disclose